These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22401962)

  • 21. Prevalence of drug resistant Mycobacterium tuberculosis among children in China.
    Jiao WW; Liu ZG; Han R; Zhao XQ; Dong F; Dong HY; Huang HR; Li QJ; Lin N; Song WQ; Wan KL; Shen AD
    Tuberculosis (Edinb); 2015 May; 95(3):315-20. PubMed ID: 25814302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fourth national anti-tuberculosis drug resistance survey in Peru.
    Quispe N; Asencios L; Obregon C; Velásquez GE; Mitnick CD; Lindeborg M; Jave H; Solari L
    Int J Tuberc Lung Dis; 2020 Feb; 24(2):207-213. PubMed ID: 32127106
    [No Abstract]   [Full Text] [Related]  

  • 23. Recognition of specific immunogenic antigens with potential diagnostic value in multi-drug resistant Mycobacterium tuberculosis inducing humoral immunity in MDR-TB patients.
    Hadizadeh Tasbiti A; Badmasti F; Siadat SD; Fateh A; Yari F; GHzanfari Jajin M; Yari S
    Infect Genet Evol; 2022 Sep; 103():105328. PubMed ID: 35788051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.
    Rando-Segura A; Aznar ML; Moreno MM; Espasa M; Sulleiro E; Bocanegra C; Gil E; Eugénio ANE; Escartin C; Zacarias A; Vegue J; Katimba D; Vivas MC; Gabriel E; Marina MC; Mendioroz J; López MT; Pumarola T; Molina I; Tórtola MT
    Emerg Infect Dis; 2018 Mar; 24(3):569-572. PubMed ID: 29460748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
    Al-Mutairi NM; Ahmad S; Mokaddas EM
    Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014.
    Diarra B; Goita D; Tounkara S; Sanogo M; Baya B; Togo AC; Maiga M; Sarro YS; Kone A; Kone B; M'Baye O; Coulibaly N; Kassambara H; Cisse A; Belson M; Polis MA; Otu J; Gehre F; Antonio M; Dao S; Siddiqui S; Murphy RL; de Jong BC; Diallo S
    BMC Infect Dis; 2016 Nov; 16(1):714. PubMed ID: 27894266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timely diagnosis of MDR-TB under program conditions: is rapid drug susceptibility testing sufficient?
    Yagui M; Perales MT; Asencios L; Vergara L; Suarez C; Yale G; Salazar C; Saavedra M; Shin S; Ferrousier O; Cegielski P
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):838-43. PubMed ID: 16898366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
    Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
    Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additional Drug Resistance in Patients with Multidrug-resistant Tuberculosis in Korea: a Multicenter Study from 2010 to 2019.
    Lee T; Lee SJ; Jeon D; Lee HY; Kim HJ; Kang BH; Mok J
    J Korean Med Sci; 2021 Jul; 36(26):e174. PubMed ID: 34227261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
    Espinal MA; Kim SJ; Suarez PG; Kam KM; Khomenko AG; Migliori GB; Baéz J; Kochi A; Dye C; Raviglione MC
    JAMA; 2000 May; 283(19):2537-45. PubMed ID: 10815117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis.
    Brady MF; Coronel J; Gilman RH; Moore DA
    J Vis Exp; 2008 Aug; (17):. PubMed ID: 19066507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
    Javaid A; Hasan R; Zafar A; Chaudry MA; Qayyum S; Qadeer E; Shaheen Z; Agha N; Rizvi N; Afridi MZ; Chima MK; Khan AR; Ghafoor A; Khan S; Awan SR; Akhtar S; Choudry K; Iqbal ZH; Ansarie M; Ahmad N
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):303-308. PubMed ID: 28225340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and drug resistance pattern of MDR TB in retreatment cases of Punjab, Pakistan.
    Akhtar AM; Arif MA; Kanwal S; Majeed S
    J Pak Med Assoc; 2016 Aug; 66(8):989-93. PubMed ID: 27524534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accounting for autocorrelation in multi-drug resistant tuberculosis predictors using a set of parsimonious orthogonal eigenvectors aggregated in geographic space.
    Jacob BJ; Krapp F; Ponce M; Gottuzzo E; Griffith DA; Novak RJ
    Geospat Health; 2010 May; 4(2):201-17. PubMed ID: 20503189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China.
    Shi W; Davies Forsman L; Hu Y; Zheng X; Gao Y; Li X; Jiang W; Bruchfeld J; Diwan VK; Hoffner S; Xu B
    Int J Infect Dis; 2020 Jul; 96():390-397. PubMed ID: 32353546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The fourth national anti-tuberculosis drug resistance survey in Viet Nam.
    Nhung NV; Hoa NB; Sy DN; Hennig CM; Dean AS
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):670-5. PubMed ID: 25946357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Geographic predictors of primary multidrug-resistant tuberculosis cases in an endemic area of Lima, Peru.
    Shah L; Choi HW; Berrang-Ford L; Henostroza G; Krapp F; Zamudio C; Heymann SJ; Kaufman JS; Ciampi A; Seas C; Gotuzzo E; Brewer TF
    Int J Tuberc Lung Dis; 2014 Nov; 18(11):1307-14. PubMed ID: 25299862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis drug resistance and outcomes among tuberculosis inpatients in Lilongwe, Malawi.
    Vorkas C; Kayira D; van der Horst C; Hoffman I; Hosseinipour M; Kanyemba C; Nguluwe N; Chikaonda T; Kalikhoka M; Kalaundi D; Namarika D; Gilligan P; Krysiak R
    Malawi Med J; 2012 Jun; 24(2):21-4. PubMed ID: 23638265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
    Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
    Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.